Navigation Links


Tolerability at Biology News

Tolerability at Biology Products
Tolerability at Biology Technology
Tolerability at Medicine News

Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment

The German pharmaceutical company Grunenthal GmbH presented the first clinical evidence for the efficacy and tolerability of tapentadol ER (extended release) for patients suffering from chronic pain at the Annual Congress of the European League Against Rheumatism (EULAR), 13-16 June 2007, Barcelona, Spain. Tapentadol, a centrally acting analgesic, is the first of its kind, combining two...
Tolerability at Medicine Products
Tolerability at Medicine Technology

First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes

-- Additional Findings Reported on Glucose Homeostasis Effects inNormal and Diabetic Rats -- CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- In a 14-day,Phase IIa study of the safety profile of multiple doses of theinvestigational compound dapagliflozin, a selective inhibitor ofthe Sodium-Glucose Transporter 2 (SGLT2) administered alone orconcomitantly with metformin in subjects with Typ...

Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial

MENLO PARK, Calif.--(BUSINESS WIRE)--Jun 12, 2007 - GeronCorporation's (Nasdaq:GERN) telomerase inhibitor cancer drug,GRN163L, has demonstrated good pharmacokinetics and tolerability inits ongoing Phase I/II trial involving patients with chroniclymphocytic leukemia (CLL), according to data presented today byAlan Colowick, M.D., M.P.H., the company's president, oncology, atthe Pan Pacific Ly...

OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation

Orexigen(TM) is evaluating zonisamide SR as a novel component inEMPATIC(TM) Phase IIb obesity trial SAN DIEGO, June 07, 2007 /PRNewswire-FirstCall/ -- Orexigen(TM)Therapeutics, Inc. , a biopharmaceutical company focused on thetreatment of central nervous system disorders with an initial focuson obesity, today announced results from a Phase I trial evaluatingsafety and pharmacokinetics of...

Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedical's Electroporation DNA Delivery Technology

SAN DIEGO--(BUSINESS WIRE)--Jun 7, 2007 - Inovio BiomedicalCorporation (AMEX:INO), focused on the development of DNA vaccinesfor cancers and infectious diseases and a novel alternative tosurgery to treat localized cancers, announced today that thecompany's partner, Vical Incorporated, presented positive interimsafety and tolerability data on 18 subjects from an ongoing Phase Iclinical trial...

Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial

EMERYVILLE, Calif., June 04, 2007 /PRNewswire-FirstCall/ --Bionovo, Inc.'s lead drug candidate, MF101, showed positive Phase 2results for the treatment of hot flashes associated with menopause.Two hundred and seventeen women were enrolled in the company'sdouble-blind, placebo- controlled, randomized Phase 2 trial.Postmenopausal women with 50 or more moderate to severe hot flashesper week...

More>>

Other TagsLardConditiConditiContraContraContraContraContraInteres
(Date:12/2/2008)... UCSF Medical Center ranks No. 1 nationw... are treated using balloon angioplasty, according ...). , (Vocus) December 2, ... for the speed with which heart attack patients ar...the National Cardiovascular Data Registry (NCDR). ...
(Date:12/2/2008)... United American Healthc... provides comprehensive healthcare,management ser... today,announced that its Board of Directors has ...the Company to repurchase up to $1.0 million of it...allows for the Company,s common shares to be purch...
(Date:12/2/2008).... 2 In an open letter t...on of Homes and Services for the Aging (AAHSA) Pre...s that the Obama administration can make both shor...e way America cares for its most vulnerable people...nd the Nation,s Work Force: Create Jobs in Aging S...
(Date:12/2/2008)...ients are having the procedure, study says , ...with the most common form of epilepsy who don,t re..., and dramatically improved quality of life at tha..., That,s the finding of a new study that relied o...ery of the temporal lobe region for people with te...
Breaking Medicine News(10 mins):Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3
(Date:12/2/2008)... due to climate change, pollution and human activi...viding satellite data of the region for the last 1...with ESA,s future missions will be key in implemen...called ,The European Union and the Arctic Region,....e region such as the opening up of long-sought tra...
(Date:12/1/2008)...tomic Energy Agency (IAEA) today called for increa...could bolster efforts aimed at pulling millions of...s use radiation to produce improved high-yielding ... as drought or flood, or that are resistant to cer...duction, the technique is safe, proven and cost-ef...
(Date:12/1/2008)...of a rare mineral that can be used to track ancien...wenstein is helping climatologists and others bett...next century or two as global warming begins to cr...s we know it. , "I think the earth will be a ve..., and that many species will adapt to it and many ...
(Date:12/1/2008)...nia Institute of Technology (Caltech) have created...or the first time, the connection between the conf...eart contracts. , More precisely, they showed th... chambers of the heart in a helix--is actually a s...on of the heart travels. , Their findings were p...
Breaking Biology News(10 mins):ESA satellites focusing on the Arctic 2Nuclear science for food security 2Foretelling a major meltdown 2Foretelling a major meltdown 3Caltech scientists show function of helical band in heart 2Emergency responders at high risk to miss work because of injuries 9160 1Emergency responders at high risk to miss work because of injuries 9160 2Emergency responders at high risk to miss work because of injuries 9160 3Scientific evidence supporting evolution continues to grow 1795 1Scientific evidence supporting evolution continues to grow 1795 2Scientific evidence supporting evolution continues to grow 1795 3Cardinal Health to Announce Second Quarter Results on January 29 9154 1Cardinal Health to Announce Second Quarter Results on January 29 9154 2Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening 9150 1Parkway Clinical Laboratories Expands Management Team to Support a National Growth Strategy Centered on Oral Fluid Drug Screening 9150 2
Other Contentslistlistlistlistlistlistlistlistlistpotentiationpotentiationtermtermtermtermtermtermtermtermtermtermlonglonglonglonglonglonglonglonglonglonglocuslocuslocuslocuslocuslocuspasteurlunglunglunglunglunglunglunglunglunghypothesishypothesishypothesishypothesishypothesishypothesis